Other Information
−Removed: Agreement, dated as of November 22, 2023, between Modular Medical, Inc.
−Removed: and Leerink Partners LLC
−Removed: Medical, Inc.
−Removed: Two-Part FDA Submission and Clearance Milestone Bonus Program
−Removed: Certification
−Removed: of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification
−Removed: of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification
−Removed: of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section
−Removed: 906 of the Sarbanes-Oxley Act of 2002
−Removed: XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Third Amendment to Employment Agreement between the Registrant and Paul DiPerna
+Added: Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
+Added: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
+Added: following financial information from Modular Medical, Inc.’s quarterly report on Form 10-Q for the period ended June 30, 2024,
+Added: filed with the SEC on August 9, 2024, formatted in Inline Extensible Business Reporting Language (Inline XBRL):
+Added: (i) the Condensed
+Added: Consolidated Statements of Operations for the three months ended June 30, 2024 and 2023, (ii) the Condensed Consolidated Balance
+Added: Sheets as of June 30 2024 and March 31, 2024, (iii) the Condensed Consolidated Statements of Stockholders’ Equity for the three
+Added: months ended June 30, 2024 and 2023, (iv) the Condensed Consolidated Statements of Cash Flows for the three months ended June 30,
+Added: 2024 and 2023, and (v) Notes to Condensed Consolidated Financial Statements.
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
−Removed: Pursuant to the requirements of the Securities Exchange Act
−Removed: of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Pursuant to the requirements of the Securities
+Added: Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MODULAR MEDICAL, INC.
−Removed: February 13, 2024
+Added: August 13, 2024
Chief Executive Officer
(Principal Executive Officer)
−Removed: Chairman, President, Chief Financial
+Added: /s/ Paul DiPerna
+Added: Chairman, President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.